My Blood Tests and Biomarker Results
Gary Leland's Function Health Biomarker Tracker
DOB: March 1, 1955 currently 71 years old - January 6, 2026 biological age 58 - June 30, 2026 biological age 56
| Category | Biomarker | Unit | Optimal / Ref | Jan 6, 2026 | Jun 30, 2026 | ||
|---|---|---|---|---|---|---|---|
| Result | Status | Result | Status | ||||
| Autoimmunity | Antinuclear Antibodies (ANA) Screen | Negative | Positive | Out of Range | |||
| Autoimmunity | Antinuclear Antibodies (ANA) Titer | <1:40 | 1:40 | Out of Range | |||
| Autoimmunity | Antinuclear Antibodies (ANA) Pattern | — | Nuclear, Homogeneous | Other | |||
| Autoimmunity | Rheumatoid Factor (RF) | IU/mL | <14 | <10 | In Range | ||
| Biological Age | Biological Age | years | lower = younger | 58 Years | Other | 56 Years | |
| Blood | Hematocrit | % | 41-50 | 42.1 | In Range | 45.5 | In Range |
| Blood | Hemoglobin | g/dL | 13.5-17.5 | 14 | In Range | 15 | In Range |
| Blood | MCH | pg | 27-33 | 31.9 | In Range | 31.6 | In Range |
| Blood | MCHC | g/dL | 32-36 | 33.3 | In Range | 33 | In Range |
| Blood | MCV | fL | 80-100 | 95.9 | In Range | 96 | In Range |
| Blood | MPV | fL | 9-13 | 9.7 | In Range | 9.8 | In Range |
| Blood | Platelet Count | Thousand/uL | 150-400 | 319 | In Range | 237 | In Range |
| Blood | RBC Count | Million/uL | 4.2-5.8 | 4.39 | In Range | 4.74 | In Range |
| Blood | RDW | % | 11.5-14.5 | 11.8 | In Range | 11.9 | In Range |
| Blood | ABO Group | — | O | Other | |||
| Blood | Rhesus (Rh) Factor | — | Rh(d) Positive | Other | |||
| Electrolytes | Calcium | mg/dL | 8.6-10.3 | 8.9 | In Range | 9.2 | In Range |
| Electrolytes | Carbon Dioxide | mmol/L | 20-29 | 23 | In Range | 25 | In Range |
| Electrolytes | Chloride | mmol/L | 98-107 | 105 | In Range | 103 | In Range |
| Electrolytes | Magnesium, RBC | mg/dL | 4.2-6.8 | 4.4 | In Range | ||
| Electrolytes | Potassium | mmol/L | 3.5-5.1 | 3.7 | In Range | 3.7 | In Range |
| Electrolytes | Sodium | mmol/L | 135-146 | 141 | In Range | 139 | In Range |
| Environmental Toxins | Lead | mcg/dL | <3.5 | <1.0 | In Range | ||
| Environmental Toxins | Mercury | mcg/L | <10 | <5 | In Range | ||
| Heart | Total Cholesterol | mg/dL | <200 | 135 | In Range | 147 | In Range |
| Heart | LDL-Cholesterol | mg/dL | <100 | 82 | In Range | 89 | In Range |
| Heart | HDL-Cholesterol | mg/dL | >40 | 40 | In Range | 45 | In Range |
| Heart | Non-HDL Cholesterol | mg/dL | <130 | 95 | In Range | 102 | In Range |
| Heart | Triglycerides | mg/dL | <150 | 47 | In Range | 44 | In Range |
| Heart | Total Cholesterol / HDL Ratio | <3.5 | 3.4 | In Range | 3.3 | In Range | |
| Heart | hs-CRP | mg/L | <1.0 | 0.3 | In Range | <0.2 | In Range |
| Heart | Apolipoprotein B (ApoB) | mg/dL | <90 | 69 | In Range | ||
| Heart | Lipoprotein (a) | nmol/L | <75 | <10 | In Range | ||
| Heart | LDL Particle Number | nmol/L | <1000 | 1356 | Above Range | ||
| Heart | LDL Small | nmol/L | <142 | 231 | Above Range | ||
| Heart | LDL Medium | nmol/L | <215 | 293 | Above Range | ||
| Heart | LDL Pattern | A (large) | B | Out of Range | |||
| Heart | LDL Peak Size | Angstrom | >222.9 | 217.2 | Below Range | ||
| Heart | HDL Large | nmol/L | >6729 | 4930 | Below Range | ||
| Immune Regulation | WBC Count | Thousand/uL | 3.4-10.8 | 7.5 | In Range | 6 | In Range |
| Immune Regulation | Neutrophils | cells/uL | 1500-7800 | 5805 | In Range | 4296 | In Range |
| Immune Regulation | Lymphocytes | cells/uL | 850-3900 | 975 | In Range | 1026 | In Range |
| Immune Regulation | Monocytes | cells/uL | 200-950 | 638 | In Range | 534 | In Range |
| Immune Regulation | Eosinophils | cells/uL | 15-500 | 53 | In Range | 102 | In Range |
| Immune Regulation | Basophils | cells/uL | 0-200 | 30 | In Range | 42 | In Range |
| Immune Regulation | Neutrophils % | % | — | 77.4 | Other | 71.6 | Other |
| Immune Regulation | Lymphocytes % | % | — | 13 | Other | 17.1 | Other |
| Immune Regulation | Monocytes % | % | — | 8.5 | Other | 8.9 | Other |
| Immune Regulation | Eosinophils % | % | — | 0.7 | Other | 1.7 | Other |
| Immune Regulation | Basophils % | % | — | 0.4 | Other | 0.7 | Other |
| Kidney | Creatinine | mg/dL | 0.76-1.27 | 0.69 | Below Range | 0.81 | In Range |
| Kidney | BUN | mg/dL | 8-27 | 12 | In Range | 13 | In Range |
| Kidney | BUN / Creatinine Ratio | 9-23 | 17 | In Range | |||
| Kidney | eGFR | mL/min/1.73m2 | >59 | 100 | In Range | 94 | In Range |
| Kidney | Albumin, Random Urine | mg/dL | — | 0.3 | Other | ||
| Liver | ALT | U/L | 0-44 | 9 | In Range | 9 | In Range |
| Liver | AST | U/L | 0-40 | 12 | In Range | 12 | In Range |
| Liver | ALP | U/L | 44-121 | 48 | In Range | 42 | In Range |
| Liver | GGT | U/L | 0-65 | 19 | In Range | ||
| Liver | Albumin | g/dL | 3.6-5.1 | 4.1 | In Range | 4.4 | In Range |
| Liver | Globulin | g/dL | 1.9-3.7 | 2.2 | In Range | 2.1 | In Range |
| Liver | Albumin / Globulin Ratio | 1.0-2.5 | 1.9 | In Range | 2.1 | In Range | |
| Liver | Total Protein | g/dL | 6.0-8.5 | 6.3 | In Range | 6.5 | In Range |
| Liver | Total Bilirubin | mg/dL | 0.2-1.2 | 0.7 | In Range | 0.9 | In Range |
| Male Health | Testosterone, Total | ng/dL | 264-916 | 1159 | Above Range | ||
| Male Health | Testosterone, Free | pg/mL | 46-224 | 85.9 | In Range | ||
| Male Health | SHBG | nmol/L | 17-77 | 86 | Above Range | ||
| Male Health | DHEA Sulfate | mcg/dL | 30-135 | 59 | In Range | ||
| Male Health | Estradiol (E2) | pg/mL | — | 66 | Other | ||
| Male Health | FSH | mIU/mL | — | 6.2 | Other | ||
| Male Health | LH | mIU/mL | — | 5.4 | Other | ||
| Male Health | Prolactin | ng/mL | — | 3.1 | Other | ||
| Male Health | PSA, Total | ng/mL | <4.0 | 0.2 | In Range | ||
| Male Health | PSA, Free | ng/mL | — | 0.1 | In Range | ||
| Male Health | PSA %, Free | % | >25 | 50 | In Range | ||
| Metabolic | Glucose | mg/dL | 70-99 | 81 | In Range | 74 | In Range |
| Metabolic | Hemoglobin A1c (HbA1c) | % | <5.7 | 5.1 | In Range | 5 | In Range |
| Metabolic | Insulin | uIU/mL | 2-19 | 3.1 | In Range | 2.9 | In Range |
| Metabolic | Leptin | ng/mL | 0.5-13.8 | 1 | In Range | ||
| Metabolic | Uric Acid | mg/dL | 3.7-8.6 | 6.2 | In Range | ||
| Nutrients | Iron | mcg/dL | 38-169 | 185 | Above Range | ||
| Nutrients | Iron % Saturation | % | 15-55 | 72 | Above Range | ||
| Nutrients | Iron Binding Capacity | mcg/dL | 250-450 | 256 | In Range | ||
| Nutrients | Ferritin | ng/mL | 30-400 | 91 | In Range | ||
| Nutrients | Vitamin D | ng/mL | 30-100 | (>150) | Above Range | ||
| Nutrients | Zinc | mcg/dL | 60-130 | 57 | Below Range | ||
| Nutrients | Homocysteine | umol/L | <15 | 9.2 | In Range | ||
| Nutrients | Methylmalonic Acid (MMA) | nmol/L | <250 | 148 | In Range | ||
| Nutrients | Omega-3 Total / OmegaCheck | % by wt | >5.4 | 5.5 | In Range | ||
| Nutrients | Omega-3: DHA | % by wt | — | 3.4 | In Range | ||
| Nutrients | Omega-3: EPA | % by wt | — | 1.1 | In Range | ||
| Nutrients | Omega-3: DPA | % by wt | — | 1 | In Range | ||
| Nutrients | Omega-6: Arachidonic Acid | % by wt | — | 10.1 | In Range | ||
| Nutrients | Omega-6: Linoleic Acid | % by wt | >18.9 | 17.5 | Below Range | ||
| Nutrients | Omega 6/3 Ratio | <8 | 5.5 | In Range | |||
| Nutrients | Arachidonic Acid/EPA Ratio | <11 | 9.1 | In Range | |||
| Pancreas | Amylase | U/L | 28-100 | 32 | In Range | ||
| Pancreas | Lipase | U/L | 11-82 | 14 | In Range | ||
| Stress & Aging | Cortisol | mcg/dL | 4-22 | 5.9 | In Range | ||
| Stress & Aging | DHEA Sulfate | mcg/dL | 30-135 | 59 | In Range | ||
| Thyroid | TSH | mIU/L | 0.45-4.5 | 1.67 | In Range | ||
| Thyroid | Thyroxine (T4) Free | ng/dL | 0.82-1.77 | 1.3 | In Range | ||
| Thyroid | Triiodothyronine (T3) Free | pg/mL | 2.0-4.4 | 2.9 | In Range | ||
| Thyroid | Thyroid Peroxidase Antibodies (TPO) | IU/mL | <9 | <1 | In Range | ||
| Thyroid | Thyroglobulin Antibodies (TgAb) | IU/mL | <1 | <1 | In Range | ||
| Urine | pH | 5.0-8.0 | 5.5 | In Range | <=5.0 | In Range | |
| Urine | Specific Gravity | 1.005-1.030 | 1.006 | In Range | 1.008 | In Range | |
| Urine | Ketones | Negative | Negative | In Range | Trace | Out of Range | |
| Urine | Glucose | Negative | Negative | In Range | Negative | In Range | |
| Urine | Protein | Negative | Negative | In Range | Negative | In Range | |
| Urine | Occult Blood | Negative | Negative | In Range | Negative | In Range | |
| Urine | Leukocyte Esterase | Negative | Negative | In Range | Negative | In Range | |
| Urine | Nitrite | Negative | Negative | In Range | Negative | In Range | |
| Urine | Bilirubin | Negative | Negative | In Range | Negative | In Range | |
| Urine | Bacteria | None Seen | None Seen | In Range | None Seen | In Range | |
| Urine | WBC | None Seen | None Seen | In Range | None Seen | In Range | |
| Urine | RBC | None Seen | None Seen | In Range | None Seen | In Range | |
| Urine | Squamous Epithelial Cells | None Seen | None Seen | In Range | None Seen | In Range | |
| Urine | Hyaline Casts | None Seen | None Seen | In Range | None Seen | In Range | |
| Urine | Appearance | Clear | Clear | In Range | Clear | In Range | |
| Urine | Color | Yellow | Yellow | In Range | Yellow | In Range | |
Whole Genome Test
| Category | Finding | Result |
|---|---|---|
| MONOGENIC | Single-gene disease variants (2,011 genes screened) | None found |
| LONGEVITY | FOXO3 | Favorable variant at both sites tested |
| RISK — HIGH | Rheumatoid arthritis | 96th percentile — 1.8× average |
| RISK — HIGH | Atrial fibrillation | 92nd percentile — 1.9× average |
| RISK — LOW | Age-related macular degeneration | 1st percentile |
| RISK — LOW | Colorectal cancer | 2nd percentile |
| RISK — LOW | Type 2 diabetes | 4th percentile |
| RISK — LOW | Melanoma | 5th percentile |
| RISK — LOW | Blood clots (venous thromboembolism) | 6th percentile |
| RISK — LOW | Prostate cancer | 20th percentile |
| RISK — LOW | Coronary artery disease | 32nd percentile |
| CANCER OVERALL | Eight cancers screened | Six below average risk |
| LIPIDS | LDL, total cholesterol, HDL, triglycerides | All below average genetic risk |
Genome Said, Blood Said
The reason to put these on one page: the genome makes predictions, and the panel above measures whether they came true.
| Marker | Genome predicted | Blood measured | Verdict |
|---|---|---|---|
| Vitamin B12 | Reduced levels likely | Methylmalonic acid normal | Prediction wrong |
| Vitamin D | Susceptible to deficiency | Above reference range | Right, but I overcorrected — cutting the dose |
| Vitamin B6 | Decreased levels likely | Not yet on my panel | Open — adding it to the January 2027 draw |
What is not published here, on purpose. My raw genotypes, variant IDs, carrier status and drug-metabolism results stay private. Raw genetic data is permanent and identifying, it says things about my children they did not choose to make public, and GINA protects you on health insurance and employment but not on life, long-term care or disability insurance. Everything above is conclusions, not source data.



